K252a is a potent and selective inhibitor of phosphorylase kinase
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 171 (1) , 148-154
- https://doi.org/10.1016/0006-291x(90)91369-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Potent selective inhibitors of protein kinase CFEBS Letters, 1989
- A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activityInternational Journal of Cancer, 1989
- Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor actionBiochemical Pharmacology, 1988
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1986
- Adult muscle phosphorylase "b" kinase deficiencyNeurology, 1986
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986
- Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase CBiochemistry, 1984
- A female case of glycogen storage myopathy due to phosphorylase kinase deficiencyJournal of Inherited Metabolic Disease, 1982
- Identification of the Ca2+‐dependent modulator protein as the fourth subunit of rabbit skeletal muscle phosphorylase kinaseFEBS Letters, 1978
- The role of magnesium in muscle phosphorylase kinase activityBiochimica et Biophysica Acta (BBA) - Enzymology, 1972